IBIzabela Brynczka

Izabela Brynczka

*This is an algorithmically generated author record based on publicly available information.

Izabela Brynczka has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Review of Candida auris

    by Marta Krzyzaniak, Izabela Brynczka, Klaudia Martyna Patrzykąt, Zofia Gorzoch- Burduk, Julia Puzio, Paula Marcinkowska, Michał Jezierski, Kinga Popielarska, Ewelina Nowicka, Kamila Wróblewska

    Background. Candida auris is an emerging, multidrug-resistant fungal pathogen ofsignificant public health concern. Noted for its environmental persistence and hightransmissibility, it poses a substantial threat in healthcare settings, particularly inintensive care units, driving the need for specific infection control protocols. Aim. The aim of this study was a comparative analysis of environmental disinfectionmethods used in the prevention and control of Candida auris in various countries andhealthcare facilities.Material and methods. This review analyzed literature from 2016-2025, sourcedfrom databases such as PubMed, alongside public health guidelines andepidemiological reports. A comparative analysis of the selected data wasconducted. Results. Disinfection strategies against C. auris primarily recommend chlorine- andhydrogen peroxide-based agents, with UV-C and vaporized hydrogen peroxide (VHP)noted as supplementary measures. A comparative analysis revealed significantinternational divergence, particularly regarding quaternary ammonium compounds(QACs), which are largely restricted except in specific contexts like India. Overallefficacy is highly variable and dependent on disinfectant selection, workflow, stafftraining, and the consistency of protocol implementation. Conclusions. Chlorine- and peroxide-based disinfectants are most effective against C.auris, while QACs are discouraged despite their localized use. To counter variabilityin international guidelines, a unified regulatory framework is recommended. Keyrecommendations include standardizing procedures, enhancing staff training, andmaintaining strict surveillance. Further research, including hospital case studies, isneeded due to insufficient current data.

  • Open Access

    A Review of Candida auris

    by Marta Krzyzaniak, Izabela Brynczka, Klaudia Martyna Patrzykąt, Zofia Gorzoch- Burduk, Julia Puzio, Paula Marcinkowska, Michał Jezierski, Kinga Popielarska, Ewelina Nowicka, Kamila Wróblewska

    Background. Candida auris is an emerging, multidrug-resistant fungal pathogen ofsignificant public health concern. Noted for its environmental persistence and hightransmissibility, it poses a substantial threat in healthcare settings, particularly inintensive care units, driving the need for specific infection control protocols. Aim. The aim of this study was a comparative analysis of environmental disinfectionmethods used in the prevention and control of Candida auris in various countries andhealthcare facilities.Material and methods. This review analyzed literature from 2016-2025, sourcedfrom databases such as PubMed, alongside public health guidelines andepidemiological reports. A comparative analysis of the selected data wasconducted. Results. Disinfection strategies against C. auris primarily recommend chlorine- andhydrogen peroxide-based agents, with UV-C and vaporized hydrogen peroxide (VHP)noted as supplementary measures. A comparative analysis revealed significantinternational divergence, particularly regarding quaternary ammonium compounds(QACs), which are largely restricted except in specific contexts like India. Overallefficacy is highly variable and dependent on disinfectant selection, workflow, stafftraining, and the consistency of protocol implementation. Conclusions. Chlorine- and peroxide-based disinfectants are most effective against C.auris, while QACs are discouraged despite their localized use. To counter variabilityin international guidelines, a unified regulatory framework is recommended. Keyrecommendations include standardizing procedures, enhancing staff training, andmaintaining strict surveillance. Further research, including hospital case studies, isneeded due to insufficient current data.

  • Open Access

    Urban-Rural Disparities in Bronchial Asthma: A Review of Environmental Determinants and Epidemiological Insights

    by Wiktoria Cecuła, Kamil Ciechomski, Joanna Rypel-Bośka, Natalia Siuta, Elżbieta Siuda, Aleksandra Stupecka, Marcin Migiel, Izabela Brynczka, Klaudia Goleniewska, Jakub Miaśnikiewicz

    Introduction and aim of the study. Bronchial asthma, as defined by the Global Initiative for Asthma (GINA, 2024), is a heterogeneous disease characterized by chronic inflammation of the airways. This study aims to investigate the impact of environmental factors, including air quality and early-life exposure to microbiota, on the prevalence and development of asthma in urban and rural populations. Brief overview of the current state of knowledge. Asthma currently affects approximately 300 million people worldwide, with its prevalence increasing, especially in industrialized countries. Exposure of children to diverse microbiota, typical of farming environments, is associated with a lower risk of developing asthma and atopic diseases, which supports the hygiene hypothesis. In contrast, air pollution in urban agglomerations-especially particulate matter (PM2.5, PM10), nitrogen oxides, and polycyclic aromatic hydrocarbons-represents a significant risk factor. The pathomechanism of asthma involves complex immune responses in which chronic inflammation and bronchial hyperresponsiveness are modulated by environmental factors. Epidemiological studies indicate a higher prevalence of asthma in cities, which is associated with reduced immune stimulation by diverse microflora and increased exposure to pollutants. Conclusion. Available data confirm the complex role of environmental factors in the etiology of asthma. Preventive strategies should include reducing air pollution, especially in urban areas, and promoting safe contact of children with natural microbiota. Further research integrating epidemiology, immunology, and environmental protection is essential to develop effective strategies for asthma prevention and treatment.

  • Open Access

    The Impact of Long-Term Running on the Development of Osteoarthritis: A Literature Review

    by Zofia Gorzoch-Burduk, Ewelina Nowicka, Izabela Brynczka, Klaudia Martyna Patrzykąt, Julia Puzio, Paula Marcinkowska, Marta Krzyżaniak, Michał Jezierski, Kinga Popielarska, Kamila Wróblewska

    Background: Osteoarthritis is a common condition that exerts a substantial impact on patients’ quality of life. It is associated with chronic joint pain, stiffness, and functional limitations. The prevalence of osteoarthritis continues to increase due to its strong association with aging and obesity. Running is a popular form of physical activity that provides numerous well-established health benefits. Determining its relationship with osteoarthritis is therefore of great importance. Aim: The aim of this study was to determine how long-term running, currently one of the most popular sports, influences the development of osteoarthritis of the lower-limb joints. Material and Methods: A literature review of publications from recent years was conducted to identify and summarize the most relevant findings and reports on this topic. Results: The findings were inconclusive. Recreational running, according to most sources, appears to be neutral or beneficial for joint health. Physicians should recommend this form of activity due to its substantial health advantages across numerous domains. However, high-level competitive, elite, and olympic running has been associated with an increased risk of developing osteoarthritis. Conclusions: High-intensity running that may lead to injuries contributing to the development of osteoarthritis should be avoided, but recreational running should not be given up.

  • Open Access

    Metformin in Breast Cancer: Molecular Mechanisms, Preclinical Evidence and Clinical Implications

    by Ewelina Nowicka, Izabela Brynczka, Klaudia Martyna Patrzykąt, Zofia Gorzoch-Burduk, Julia Puzio, Paula Marcinkowska, Marta Krzyżaniak, Michał Jezierski, Kinga Popielarska, Kamila Wróblewska

    Background: Metformin, a first-line therapy for type 2 diabetes mellitus, has recently attracted attention for its potential anticancer properties. Preclinical and clinical evidence suggests that it modulates cancer cell metabolism, proliferation and survival pathways, indicating its possible role as an adjunct therapeutic agent, particularly in breast cancer. Aim: To summarize current knowledge on the mechanisms of action, preclinical outcomes and clinical implications of metformin use in breast cancer. Material and methods: A comprehensive literature search was conducted in PubMed, Scopus, Web of Science and Google Scholar databases, including publications up to 2025. Eligible sources encompassed preclinical studies, clinical trials, observational data, meta-analyses and reviews addressing metformin in breast cancer. Results: Metformin demonstrates multifaceted antitumor activity, including inhibition of cell proliferation, reduced angiogenesis, downregulation of the PI3K/AKT/mTOR pathway, depletion of cancer stem cell populations and improved chemotherapy response. Clinical benefits are most evident in patients with type 2 diabetes and HER2-positive tumors, although findings in the general population remain inconsistent. Conclusions: Metformin appears to be a promising supportive therapy in selected breast cancer subgroups, particularly in metabolically burdened patients. Further high-quality randomized trials are essential to clarify its clinical relevance and identify biomarkers predicting treatment response.

  • Open Access

    Xylitol, erythritol as sucrose replacements: their effect on oral health - narrative review

    by Julia Puzio, Izabela Brynczka, Zofia Gorzoch-Burduk, Michał Jezierski, Marta Krzyżaniak, Ewelina Nowicka, Paula Marcinkowska, Kinga Popielarska, Klaudia Martyna Patrzykąt, Kamila Wróblewska

    Background:Dental caries in one of the most common chronic diseases worldwide. Sucrose consumption is one of the main cause of dental caries due to biofilm acidification, microbial dysbiosis, and demineralization.Researchers have centered their attention on developing sucrose substitutes with special emphasis on polyols, which can reduce cariogenicity. Aim: This narrative review aims to integrate existing evidence with regard to the mechanism of action, clinical efficacy, and safety usage of xylitol, erythritol, in relation to preventing dental caries, maintaining periodontal and overall oral health. Methods: This narrative review was conducted through structured research of PubMed (2015-2025).Recent clinical trials, in vitro studies, systematic reviews were included. Results: Xylitol demonstrates consistent inhibition effects on S.mutans, reduced biofilm adhesive properties, lowered acid production leading to a gradual change in cariogenic oral microbiome. Erythritol is found with similar or better activity levels in most studies. Unlike sucrose, polyols lack the fermentable activity, preventing a lowered pH and subsequent enamel demineralization. Conclusions:Sucrose substitutes have emerged as potential efficacious and biologically credible additions to established prophylactic modalities. Their abilities, makes theme promising additions to caries prophylaxis and initial periodontal therapy itself. There is a need for further well-designed clinical studies to establish a precise dosage and efficacy of these substances.

  • Open Access

    Continuous Glucose Monitoring Systems: Applications and Integrated Benefits - review study

    by Klaudia Goleniewska, Jakub Miasnikiewicz, Kamil Ciechomski, Wiktoria Cecuła, Joanna Rypel-Bośka, Natalia Siuta, Aleksandra Stupecka, Marcin Migiel, Izabela Brynczka

    Introduction: Continuous Glucose Monitoring (CGM) systems have evolved significantly, transforming the management of diabetes and expanding into various other fields. Originally developed to aid in diabetes management, CGM systems now offer real-time glucose tracking, providing insights into glycemic control, preventing hypoglycemia, and optimizing therapeutic decisions. These systems are used in type 1 and type 2 diabetes management, pregnancy, sports, and critical care. Despite their benefits, challenges such as cost and integration into routine care remain. Future research will be crucial to fully understand the long-term impact and cost-effectiveness of CGM systems. Aim of the study: This study aims to present the diverse applications and integrated benefits of Continuous Glucose Monitoring (CGM) systems. It focuses on their role in improving diabetes management, enhancing pregnancy outcomes, supporting athletic performance, and optimizing care in critical conditions. Materials and methods: A literature review was conducted using PubMed as the primary database. The search terms included: "continuous glucose monitoring", “CGM”, “diabetes mellitus", “diabetes mellitus type 1”, “diabetes mellitus type 2”. Conclusion: Continuous glucose monitoring (CGM) systems have significantly advanced diabetes care, offering precise, real-time glycemic data that support individualized treatment. This review highlights CGM’s broadening applications across diverse populations, including non-diabetic individuals, pregnant women, athletes, and critically ill patients. While strong evidence supports CGM’s clinical and behavioral benefits, further research is required to optimize cost-effectiveness, long-term outcomes, and broader implementation strategies. CGM represents a transformative tool in both chronic disease management and personalized health monitoring.

  • Open Access

    Multiple Myeloma: Impact on the Skeletal System - a Review of the Literature

    by Aleksandra Stupecka, Kamil Ciechomski, Wiktoria Cecuła, Joanna Rypel-Bośka, Natalia Siuta, Marcin Migiel, Izabela Brynczka, Klaudia Goleniewska, Jakub Miaśnikiewicz

    Background. Multiple myeloma is a cancerous disease of the hematopoietic system marked by the uncontrolled proliferation of monoclonal plasma cells within the bone marrow. Bone disease is a characteristic feature and a diagnostic criterion of multiple myeloma. Aim. This paper aims to discuss the pathophysiological mechanisms underlying bone damage in multiple myeloma and to present current diagnostic and therapeutic approaches designed to improve clinical outcomes in patients affected by myeloma bone disease. Material and methods. A review of the scientific literature from the past eight years was conducted using topic-specific keywords, primarily through databases such as PubMed and Google Scholar. Results. Bone mass loss is a complex process that involves elevated osteoclast activity, impaired osteoblast function, and the release of pro-inflammatory cytokines, resulting in a disruption of the balance between bone resorption and formation. As a consequence, patients may develop chronic bone pain, pathological fractures, and postural changes. Therapeutic strategies that aim to slow the course of the disease and inhibit osteoclast activity are essential for minimizing the risk of skeletal-related complications and markedly enhancing patients' quality of life. Conclusion. Multiple myeloma is a malignancy that frequently leads to bone damage. This review discusses the underlying mechanisms, diagnostic methods, and current treatments aimed at preventing skeletal complications and improving patient outcomes

  • Open Access

    Taurine in Sports: Impact on Athletic Performance, Muscle Recovery and Neurological Function in Athletes – A Narrative Review

    by Michał Jezierski, Izabela Brynczka, Klaudia Martyna Patrzykąt, Zofia Gorzoch-Burduk, Julia Puzio, Paula Marcinkowska, Marta Krzyżaniak, Kinga Popielarska, Ewelina Nowicka, Kamila Wróblewska

    Purpose: This review examines the ergogenic potential of taurine in athletes, focusing on its effects on aerobic and anaerobic performance, exercise-induced muscle damage (EIMD), recovery, and neurological aspects such as pain perception and cognitive focus. It also considers how dose, timing, and duration (acute vs. chronic use) influence outcomes.Materials and Methods: A narrative review of 19 peer-reviewed studies (RCTs, meta-analyses, observational research) from PubMed, Scopus, and Google Scholar was conducted. Studies involved swimming, running, cycling, speed skating, and resistance training. Taurine doses ranged from 0.05–6 g/day. Outcomes included VO2max, time to exhaustion, time-trial performance, anaerobic power (Wingate, vertical jump), biomarkers of muscle damage (CK, LDH), oxidative stress (MDA, SOD, GSH), pain, and RPE.Results: Effects varied by exercise type and dosing. In anaerobic tasks, acute taurine (6 g) enhanced peak and mean power and lowered RPE in elite athletes, while broader data indicate improved vertical jump. Endurance results were inconsistent: some studies showed no changes in VO2max or time-trial performance, whereas others reported increased time to exhaustion and greater lipid use. Taurine consistently reduced CK, LDH, and MDA after exercise, especially 24–48 hours post-effort. It also affected pain perception up to 96 hours and showed neuroprotective properties in animal models.Conclusions: Taurine is a safe option for reducing EIMD and oxidative stress, supporting recovery. Ergogenic benefits appear stronger in anaerobic, high-power activities than in endurance sports, where outcomes are mixed and may relate to non-responder effects in elite athletes. Taurine’s influence on lipid metabolism and lactate kinetics suggests support for anaerobic energy processes. Further research should refine dosing strategies and explore neuroprotective roles in contact sports.


  • Open Access

    Old Drugs, New Roles: Non-Cardiac Uses of Beta-Blockers – An Updated Systematic Review

    by Izabela Brynczka, Michał Jezierski, Ewelina Nowicka, Klaudia Martyna Patrzykąt, Zofia Gorzoch-Burduk, Julia Puzio, Paula Marcinkowska, Marta Krzyżaniak, Kinga Popielarska, Kamila Wróblewska

    Background: β-adrenergic blockers have long been used in cardiovascular medicine, yet growing evidence shows therapeutic potential beyond cardiac disease. Their pleiotropic effects—ranging from modulation of sympathetic signaling to anti-angiogenic and immunomodulatory actions—have increased interest in non-cardiac applications and drug repurposing.Aim: To review non-cardiac roles of β-blockers, summarize recent findings (2020–2025), compare mechanisms across indications, and highlight emerging oncologic and immunomodulatory uses.Material and Methods: This narrative review was based on PubMed, Google Scholar and Scopus searches (2020–2025) using terms including “beta-blockers”, “propranolol”, “timolol”, “repurposing”, “glaucoma”, “hemangioma” and “oncology”. Randomized trials, cohort studies, translational basic research and meta-analyses were included; studies without relevance to non-cardiac mechanisms or lacking extractable data were excluded.Results: Non-selective β-blockers remain essential in portal hypertension, reducing portal pressure and preventing bleeding. In infantile hemangioma, oral propranolol is more effective than topical timolol, with early initiation predicting better outcomes. Propranolol, timolol and metoprolol are effective in migraine prophylaxis, while propranolol remains first-line therapy for essential tremor. Timolol is a cornerstone glaucoma treatment, lowering intraocular pressure and delaying progression from ocular hypertension. In oncology, propranolol shows preclinical activity against proliferation, angiogenesis and immunosuppression, though clinical evidence is inconsistent.Conclusions: β-blockers represent a versatile drug class with established non-cardiac indications and promising emerging applications, especially in oncology. Their safety and broad mechanistic profile support further repurposing, but high-quality prospective trials remain necessary.